Early Infant Diagnosis (EID)

Resource
September 4, 2018

The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Blog
July 25, 2018
Bright and early Wednesday morning, nine speakers and more than 70 participants from international development organizations, donor agencies, and academia gathered at AIDS 2018 to discuss best practices and lessons learned from The Accelerating Children’s HIV/AIDS Treatment (ACT), reflecting how we can sustain and continue to accelerate progress in reaching children and adolescents living with HIV. Participants asked thoughtful questions and engaged in lively discussion with the panel of speakers, including reflection on challenges with case identification and the need for countries to strategically position point of care diagnostics.
Resource
July 25, 2018

Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan

Resource
July 23, 2018

Since WHO published the 2016 ARV guidelines, several studies have evaluated the safety and efficacy of dolutegravir (DTG) during pregnancy and the periconcep

News
May 15, 2018

To achieve global health and development goals, experts recommend increased investments and comprehensive interventions

Resource
May 14, 2018

The Guttmacher-Lancet Commission’s report lays out the scope of the unfinished sexual and reproductive health and rights (SRHR) agenda; articulates a bold and evidence-based vision for SRHR that is grounded in human rights; provides an integrated, new definition of SRHR to guide this vis

Resource
April 18, 2018

Mortality associated with in-utero HIV infection rises rapidly within weeks after birth. Very early infant diagnosis of HIV (VEID)–testing within 2 weeks of birth–followed by immediate initiation of antiretroviral therapy has potential to avert mortality associated with in-utero transmission.